PT2047270E - Agentes de estabilização e ligandos de captura para utilização em ensaios de medição de concentrações de analito - Google Patents

Agentes de estabilização e ligandos de captura para utilização em ensaios de medição de concentrações de analito

Info

Publication number
PT2047270E
PT2047270E PT78613312T PT07861331T PT2047270E PT 2047270 E PT2047270 E PT 2047270E PT 78613312 T PT78613312 T PT 78613312T PT 07861331 T PT07861331 T PT 07861331T PT 2047270 E PT2047270 E PT 2047270E
Authority
PT
Portugal
Prior art keywords
stabilizing agents
analyte concentrations
capture ligands
assays measuring
measuring analyte
Prior art date
Application number
PT78613312T
Other languages
English (en)
Inventor
Wenyuan Lu
Katherine M Leith
Stephen P Chan
Courtney E Walton
Original Assignee
Beckman Coulter Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beckman Coulter Inc filed Critical Beckman Coulter Inc
Publication of PT2047270E publication Critical patent/PT2047270E/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PT78613312T 2006-07-28 2007-07-20 Agentes de estabilização e ligandos de captura para utilização em ensaios de medição de concentrações de analito PT2047270E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83378606P 2006-07-28 2006-07-28

Publications (1)

Publication Number Publication Date
PT2047270E true PT2047270E (pt) 2013-10-17

Family

ID=39230736

Family Applications (1)

Application Number Title Priority Date Filing Date
PT78613312T PT2047270E (pt) 2006-07-28 2007-07-20 Agentes de estabilização e ligandos de captura para utilização em ensaios de medição de concentrações de analito

Country Status (9)

Country Link
US (2) US7897352B2 (pt)
EP (1) EP2047270B1 (pt)
KR (1) KR101395954B1 (pt)
CN (1) CN101512342B (pt)
CA (1) CA2659387C (pt)
ES (1) ES2427997T3 (pt)
HK (1) HK1127642A1 (pt)
PT (1) PT2047270E (pt)
WO (1) WO2008039266A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7816090B2 (en) * 2007-01-10 2010-10-19 Ortho-Clinical Diagnostics, Inc. Multiple immunochemistry assays on an element
US20120015350A1 (en) * 2009-03-10 2012-01-19 Northwestern University Lateral flow strip and uses thereof
EP2372365A1 (en) 2010-04-01 2011-10-05 Future Diagnostics B.V. Direct immunoassay for vitamin D
AU2011353202B2 (en) 2010-12-28 2015-07-09 Future Diagnostics B.V. Release reagent for vitamin D
WO2017127833A1 (en) 2016-01-22 2017-07-27 Affimedix, Inc. Device for detection of vitamin d metabolites
JP6782785B2 (ja) * 2016-10-19 2020-11-11 栄研化学株式会社 免疫学的測定方法および測定試薬
US20200271643A1 (en) * 2017-09-20 2020-08-27 Quanterix Corporation Methods and systems for the detection of analyte molecules
CN110988367B (zh) * 2019-11-18 2024-02-09 迈克生物股份有限公司 一种贮存剂、用于检测lh的校准品及检测试剂盒

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0061541A1 (en) 1981-03-27 1982-10-06 Biospecia Limited Immunological analysis and a biochemical agent therefor
US4751190A (en) * 1985-07-22 1988-06-14 Abbott Laboratories Fluorescence polarization immunoassay and reagents for use therein
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
AU670108B2 (en) * 1992-09-11 1996-07-04 Becton Dickinson & Company Improved antibodies to plasmodium falciparum
US5627080A (en) 1994-07-29 1997-05-06 Beckman Instruments, Inc. Detergent-facilitated immunoassay for the rapid and quantitative assay of pharmacological agents
US6342389B1 (en) * 1995-04-10 2002-01-29 Roger S. Cubicciotti Modified phycobilisomes and uses therefore
EP0819119B1 (en) * 1996-01-16 2003-04-02 Lumigen, Inc. Compounds, compositions and methods for generating chemiluminescence with phosphatase enzymes
US5770380A (en) * 1996-09-13 1998-06-23 University Of Pittsburgh Synthetic antibody mimics--multiple peptide loops attached to a molecular scaffold
CN1263267A (zh) * 1999-02-08 2000-08-16 刘剑雄 抗TORCH－IgM型ELISA检测试剂盒
JP2001041958A (ja) * 1999-07-28 2001-02-16 Takeda Chem Ind Ltd 環境汚染物質の免疫学的測定分析法
US7371582B2 (en) * 2002-01-23 2008-05-13 Boditechmed Inc. Lateral flow quantitative assay method and strip and laser-induced fluorescence detection device therefor
US20030228681A1 (en) * 2002-04-05 2003-12-11 Powerzyme, Inc. Analyte sensor
CA2501601C (en) * 2002-10-25 2008-12-30 Seymour J. Kurtz Method of treating insulin resistance, adult onset diabetes and metabolic syndrome x using small unilamellar vesicles
US7713440B2 (en) * 2003-10-08 2010-05-11 Lyotropic Therapeutics, Inc. Stabilized uncoated particles of reversed liquid crystalline phase materials
US7233391B2 (en) * 2003-11-21 2007-06-19 Perkinelmer Las, Inc. Optical device integrated with well

Also Published As

Publication number Publication date
HK1127642A1 (en) 2009-10-02
KR101395954B1 (ko) 2014-05-21
EP2047270B1 (en) 2013-09-04
CA2659387C (en) 2015-06-16
EP2047270A4 (en) 2009-09-02
WO2008039266A2 (en) 2008-04-03
KR20090035025A (ko) 2009-04-08
US8450073B2 (en) 2013-05-28
EP2047270A2 (en) 2009-04-15
CN101512342B (zh) 2017-07-14
US20110091909A1 (en) 2011-04-21
WO2008039266A3 (en) 2008-06-19
CN101512342A (zh) 2009-08-19
ES2427997T3 (es) 2013-11-05
US20080182341A1 (en) 2008-07-31
CA2659387A1 (en) 2008-04-03
US7897352B2 (en) 2011-03-01

Similar Documents

Publication Publication Date Title
PT2047270E (pt) Agentes de estabilização e ligandos de captura para utilização em ensaios de medição de concentrações de analito
EP3640627A3 (en) Method for reducing corrosion in an oil refinery installation
ATE532063T1 (de) Elektrochemischer biosensor
ATE310582T1 (de) Verfahren und vorrichtung zur bestimmung des volumens einer flüssigkeitsprobe
CL2008001600A1 (es) Medidor impulsado por baterias adaptado para determinar una concentracion de analito de una muestra de fluido mediante el uso de un sensor de pruebas; y metodo asociado.
DE502006008826D1 (de) Mischpotenzialsensor zur messung einer gaskonzentration
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도
ATE555386T1 (de) Verfahren zur messung von hämoglobin und hämoglobin-derivat sowie messkit
MX2009006205A (es) Inmunoensayo de multiples analitos.
GB2436681B (en) Fluorescent assay
BR112013013991A2 (pt) método para medir pelo menos, uma propriedade de uma amostra predominantemente líquida
DK2021794T3 (da) Anvendelse af protein S100A 12 som en markør for colorektal cancer
ATE409314T1 (de) Verfahren zur beurteilung rheumatoider arthritis durch messen von anti-ccp und serumamyloid a
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
MX336940B (es) Uso de compuestos mejoradores de señal en deteccion de electroquimioluminiscencia.
WO2005124356A3 (en) Use of protein cbp2 as a marker for colorectal cancer
SG179447A1 (en) The quantitative determination of risedronate in urine by spe-lc-ms-ms
FR2894675B1 (fr) Distinction des meningites bacteriennes et virales
ATE467128T1 (de) Kolloidale metallkonjugate
NO20083133L (no) Dobbel transdermal analyttsensorsammensetning samt metoder for anvendelse derav
TW200508605A (en) Analysis method
WO2008067008A3 (en) A method for the quantitative evaluation of sex hormones in a serum sample
WO2008067007A3 (en) A method for quantitative measurement of thyroid homrones and related antibodies in a serum sample
DE602005010548D1 (de) Verbessertes verfahren zur diagnose des akuten koronarsyndroms
EA200801533A1 (ru) Производные антрахинона в качестве маркирующих веществ для жидкостей